Sunday, July 23, 2023 2:33:53 PM
Sol Gel Technologies Ltd NASDAQ: SLGL
GoSymbol lookup
Health Care : Pharmaceuticals | Small Cap Value | Based in IsraelCompany profile
Sol-Gel Technologies Ltd is a clinical-stage dermatology company. The Company is focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The Company’s offers a range of products twins, sirs-t, and vered. The Company is designed its proprietary, silica-based microencapsulation technology platform to enhance the tolerability and stability of topical drugs while maintaining their efficacy. Topical drugs often struggle to balance achieving both high efficacy and high tolerability. Its technology platform entraps active ingredients in an inert, inorganic silica shell, which creates an unnoticeable barrier between the active ingredient and the skin.
GoSymbol lookup
Health Care : Pharmaceuticals | Small Cap Value | Based in IsraelCompany profile
Sol-Gel Technologies Ltd is a clinical-stage dermatology company. The Company is focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The Company’s offers a range of products twins, sirs-t, and vered. The Company is designed its proprietary, silica-based microencapsulation technology platform to enhance the tolerability and stability of topical drugs while maintaining their efficacy. Topical drugs often struggle to balance achieving both high efficacy and high tolerability. Its technology platform entraps active ingredients in an inert, inorganic silica shell, which creates an unnoticeable barrier between the active ingredient and the skin.
I am writing a book, American Cars of 1958. Check often for the latest addition. https://investorshub.advfn.com/American-Cars-of-1958-37252/
Recent SLGL News
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/24/2026 09:16:03 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 03/24/2026 09:14:27 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 03/24/2026 04:15:06 AM
- Sol-Gel Technologies Ltd. Announces Pricing of Oversubscribed Underwritten Offering • GlobeNewswire Inc. • 03/24/2026 01:38:22 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 03/19/2026 09:03:09 PM
- Sol-Gel Files Annual Report on Form 20-F for the Year Ended December 31, 2025 • GlobeNewswire Inc. • 03/19/2026 12:53:28 PM
- Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)] • Edgar (US Regulatory) • 03/19/2026 12:51:43 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 07:12:53 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 04:26:07 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 04:24:12 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 04:20:46 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 04:18:21 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 04:15:32 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/12/2026 11:11:02 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/26/2026 11:21:09 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/24/2026 12:41:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/15/2026 11:54:30 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 12/17/2025 01:47:45 PM
- Sol-Gel Provides Update Following Unblinding of Phase 1b Study of SGT-210 in Darier Disease • GlobeNewswire Inc. • 12/17/2025 12:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/20/2025 01:44:10 PM
- Sol-Gel Reports Third Quarter 2025 Financial Results and Provides Corporate Updates • GlobeNewswire Inc. • 11/20/2025 12:30:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/14/2025 11:00:31 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/25/2025 06:12:52 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/04/2025 11:00:10 AM
- Sol-Gel Announces Health Canada Approval of EPSOLAY® • GlobeNewswire Inc. • 09/04/2025 11:00:00 AM
